Revvity (RVTY) announced it has entered into a definitive agreement to acquire ACD/Labs. The transaction is expected to close late in Q4.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- Revvity price target raised to $105 from $99 at BofA
- Revvity price target raised to $123 from $122 at Baird
- Revvity price target raised to $105 from $100 at Barclays
- Revvity, Inc. Reports Modest Growth and Strategic Initiatives
- Revvity: Buy Rating Affirmed Amid Strong Q3 Performance and Strategic Positioning